Results 91 to 100 of about 8,974,656 (216)
PLoS ONE, 2015 Background The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 with a 2+1 schedule (3, 5, 12 months) without catch-up vaccinations.
J. Jokinen +8 more
semanticscholar +1 more source
PLoS ONE, 2015 This study describes the effects of the introduction of universal infant pneumococcal conjugate vaccination in 2006 on invasive pneumococcal disease (IPD) among children and adults in Germany with a focus on the dynamics of serotype distribution in ...
M. P. van der Linden +3 more
semanticscholar +1 more source
Easy Diagnosis of Invasive Pneumococcal Disease
Emerging Infectious Diseases, 2011 Invasive pneumococcal disease (IPD) causes many cases of severe disease and death among children
Selva Jové, Laura +3 more
openaire +4 more sources
Increasing the Discovery Power and Confidence Levels of Disease Association Studies: A Survey [PDF]
arXiv, 2017 The majority of common diseases are influenced by multiple genetic and environmental factors such as Cancer. Even though uncovering the main causes of disease is deemed difficult due to the complexity of gene-gene and gene-environment interactions, major research efforts aim at identifying disease risk factors, especially genetic ones.
arxiv
Cardiotoxicity during invasive pneumococcal disease.
American Journal of Respiratory and Critical Care Medicine, 2015 Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and sepsis, with adult hospitalization linked to approximately 19% incidence of an adverse cardiac event (e.g., heart failure, arrhythmia, infarction).
A. Brown +3 more
semanticscholar +1 more source
Pneumococcal vaccination and chronic respiratory diseases
International Journal of Chronic Obstructive Pulmonary Disease, 2017 Patients with COPD and other chronic respiratory diseases are especially vulnerable to viral and bacterial pulmonary infections, which are major causes of exacerbations, hospitalization, disease progression, and mortality in COPD patients. Effective vaccines could reduce the burden of respiratory infections and acute exacerbations in COPD patients, but
F. Froes, N. Roche, F. Blasi
openaire +7 more sources
Rare but not forgotten: A case of meningitis due to ceftriaxone-resistant Streptococcus pneumoniae
IDCases, 2018 Despite the dramatic decrease in invasive pneumococcal disease since the widespread use of the first pneumococcal vaccine, invasive and resistant disease still occurs.
Naomi Hauser +3 more
doaj +1 more source
The development of nations conditions the disease space [PDF]
arXiv, 2019 Using the economic complexity methodology on data for disease prevalence in 195 countries during the period of 1990-2016, we propose two new metrics for quantifying the relatedness between diseases, or the `disease space' of countries. With these metrics, we analyze the geography of diseases and empirically investigate the effect of economic ...
arxiv
Emerging Infectious Diseases, 2015 Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes 1,
M. Knol +6 more
semanticscholar +1 more source
New Microbes and New Infections, 2015 Pneumococcal infections are a major cause of morbidity and mortality in developing countries. The introduction of pneumococcal conjugate vaccines (PCVs) has dramatically reduced the incidence of pneumococcal diseases. PCVs are not currently being used in
N. Ramdani-Bouguessa +13 more
doaj +1 more source